JP2021536461A5 - - Google Patents
Info
- Publication number
- JP2021536461A5 JP2021536461A5 JP2021512444A JP2021512444A JP2021536461A5 JP 2021536461 A5 JP2021536461 A5 JP 2021536461A5 JP 2021512444 A JP2021512444 A JP 2021512444A JP 2021512444 A JP2021512444 A JP 2021512444A JP 2021536461 A5 JP2021536461 A5 JP 2021536461A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- composition according
- reserve
- nerve
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024091680A JP2024113090A (ja) | 2018-09-05 | 2024-06-05 | 神経可塑性を誘導するための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862727420P | 2018-09-05 | 2018-09-05 | |
| US62/727,420 | 2018-09-05 | ||
| PCT/US2019/048698 WO2020051051A1 (en) | 2018-09-05 | 2019-08-29 | Methods and compositions for inducing neural plasticity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024091680A Division JP2024113090A (ja) | 2018-09-05 | 2024-06-05 | 神経可塑性を誘導するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021536461A JP2021536461A (ja) | 2021-12-27 |
| JP2021536461A5 true JP2021536461A5 (enExample) | 2022-09-06 |
| JP7589143B2 JP7589143B2 (ja) | 2024-11-25 |
Family
ID=69722599
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512444A Active JP7589143B2 (ja) | 2018-09-05 | 2019-08-29 | 神経可塑性を誘導するための方法および組成物 |
| JP2024091680A Pending JP2024113090A (ja) | 2018-09-05 | 2024-06-05 | 神経可塑性を誘導するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024091680A Pending JP2024113090A (ja) | 2018-09-05 | 2024-06-05 | 神経可塑性を誘導するための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12138300B2 (enExample) |
| EP (1) | EP3846838A4 (enExample) |
| JP (2) | JP7589143B2 (enExample) |
| KR (1) | KR102919967B1 (enExample) |
| CN (1) | CN113260373B (enExample) |
| AU (1) | AU2019334965B2 (enExample) |
| CA (1) | CA3111512A1 (enExample) |
| WO (1) | WO2020051051A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025092748A1 (zh) * | 2023-11-01 | 2025-05-08 | 拜西欧斯（北京）生物技术有限公司 | 多肽衍生物、其药物组合物及其用途 |
| TW202547546A (zh) * | 2024-02-07 | 2025-12-16 | 日商第一工業製藥股份有限公司 | 用以改善腦功能之環狀肽衍生物組成物 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2945108A1 (de) | 1979-11-08 | 1981-05-21 | Interatom Internationale Atomreaktorbau Gmbh, 5060 Bergisch Gladbach | Faltenbalgkompensator |
| FR2641360B1 (fr) | 1988-12-29 | 1991-02-22 | Commissariat Energie Atomique | Compensateur de dilatation monte entre deux tuyauteries |
| US5804604A (en) * | 1989-12-21 | 1998-09-08 | Biogen, Inc. | Tat-derived transport polypeptides and fusion proteins |
| EP0721352A4 (en) | 1993-10-01 | 1998-07-01 | Univ New York | NEW PHOSPHOTYROSINE PHOSPHATASE - -g (s) WITH RECEPTOR FUNCTION |
| WO2001016097A1 (en) | 1999-08-27 | 2001-03-08 | Sugen, Inc. | Phosphate mimics and methods of treatment using phosphatase inhibitors |
| US6841535B2 (en) * | 2000-07-31 | 2005-01-11 | Active Motif | Peptide-mediated transfection agents and methods of use |
| WO2002083182A2 (en) | 2001-04-12 | 2002-10-24 | Mcgill University | The effect of receptor protein tyrosine phosphatase sigma (rptp-$g(s)) on neural axon regeneration and synapse modification |
| US7829087B2 (en) | 2001-07-09 | 2010-11-09 | Elan Pharmaceuticals, Inc. | Methods of treating cognitive impairment |
| KR100814109B1 (ko) | 2006-01-09 | 2008-03-14 | 한국생명공학연구원 | 로다닌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 약학적 조성물 |
| US20090202544A1 (en) | 2006-02-02 | 2009-08-13 | The Trustees Of Columbia University In The City Of New York | Methods of Treating Diseases by Targeting Silt3 |
| KR100999043B1 (ko) | 2007-12-04 | 2010-12-09 | 한국생명공학연구원 | 융합 단백질을 사용하지 않는 인간 단백질 타이로신탈인산화 효소의 활성 도메인 대량 생산 방법 |
| US20120045459A1 (en) | 2009-05-05 | 2012-02-23 | Van Andel Research Institute | Methods for Treating Autophagy-Related Disorders |
| WO2010146058A1 (en) | 2009-06-15 | 2010-12-23 | Vib Vzw | Bace1 inhibitory antibodies |
| US20120231014A1 (en) | 2009-08-18 | 2012-09-13 | Case Western Reserve University | Neural Regeneration |
| US20130171163A1 (en) | 2010-08-06 | 2013-07-04 | Marschall Runge | Inhibition of LAR Phosphatase to Enhance Therapeutic Angiogenesis |
| CA2827383A1 (en) | 2011-02-18 | 2012-08-23 | President And Fellows Of Harvard College | Molecular switch for neuronal outgrowth |
| CN104270945B (zh) | 2012-03-19 | 2017-03-29 | 巴克老龄化研究所 | App特异性bace抑制剂(asbi)及其用途 |
| CA3233345A1 (en) * | 2012-04-09 | 2013-10-17 | Case Western Reserve University | Compositions and methods for inhibiting the activity of lar family phosphatases |
| US20150084328A1 (en) | 2013-09-24 | 2015-03-26 | Witzenmann Gmbh | Compensator arrangement |
-
2019
- 2019-08-29 CA CA3111512A patent/CA3111512A1/en active Pending
- 2019-08-29 EP EP19857885.8A patent/EP3846838A4/en active Pending
- 2019-08-29 WO PCT/US2019/048698 patent/WO2020051051A1/en not_active Ceased
- 2019-08-29 KR KR1020217009271A patent/KR102919967B1/ko active Active
- 2019-08-29 CN CN201980058427.8A patent/CN113260373B/zh active Active
- 2019-08-29 AU AU2019334965A patent/AU2019334965B2/en active Active
- 2019-08-29 US US17/272,393 patent/US12138300B2/en active Active
- 2019-08-29 JP JP2021512444A patent/JP7589143B2/ja active Active
-
2024
- 2024-06-05 JP JP2024091680A patent/JP2024113090A/ja active Pending
- 2024-10-31 US US18/932,666 patent/US20250255939A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7829511B2 (ja) | Ｌａｒファミリーホスファターゼの活性を阻害する組成物及び方法 | |
| Brines | The therapeutic potential of erythropoiesis-stimulating agents for tissue protection: a tale of two receptors | |
| JP2023538422A5 (enExample) | ||
| JP2021536461A5 (enExample) | ||
| JP6907229B2 (ja) | ヒト化抗ｃｌｅｖｅｒ−１抗体およびその使用 | |
| RU2021130306A (ru) | Композиции il-12, нацеленные на edb | |
| CA2730789A1 (en) | Treatment of inflammatory bowel diseases with mammal beta defensins | |
| JPWO2019156137A5 (enExample) | ||
| US9809823B2 (en) | DNA aptamers for promoting remyelination | |
| RU2010144014A (ru) | Применение пегилированных вариантов ифр-i для лечения нейромышечных расстройств | |
| JP2017532365A5 (enExample) | ||
| JP2006506942A5 (enExample) | ||
| JP2021531834A5 (enExample) | ||
| JP2022533092A5 (enExample) | ||
| CA2342770A1 (en) | Ly6h gene | |
| JP2022509445A5 (enExample) | ||
| CN107583034A (zh) | 生长分化因子11在制备缺血性脑中风疾病药物中的应用 | |
| JP2024518826A5 (enExample) | ||
| RU2012153703A (ru) | Соединения двухцепочечных рнк к rhoa и их применение | |
| JP2018521086A5 (enExample) | ||
| Mukherjee et al. | Myelin associated inhibitory proteins as a therapeutic target for healing of CNS injury | |
| US8093213B2 (en) | Heparin binding epidermal growth factor (HB-EGF) for use in methods of treating and preventing intestinal injury related to hemorrhagic shock and resuscitation | |
| JP2017524727A5 (enExample) | ||
| EP2877195B1 (en) | Method of treating optic nerve damage, ophthalmic ischemia or ophthalmic reperfusion injury | |
| CN106928322A (zh) | 一种具有抗脑缺血作用的融合多肽及其应用 |